StonvexLoading…
StonvexStonvexStonvexCore line items from SRTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $27.48M | $22.54M | $15.66M | $8.34M |
Operating Income | $-10.31M | $-7.16M | $-4.59M | $-2.65M |
Net Income | $-7.72M | $-4.55M | $-1.04M | $-2.57M |
EPS (Diluted) | $-0.47 | $-0.28 | $-0.22 | $-0.16 |
Total Assets | $53.04M | $58.30M | $58.85M | $60.21M |
Total Liabilities | $4.94M | $7.10M | $6.79M | $7.18M |
Cash & Equivalents | $22.08M | $24.45M | $22.16M | $19.07M |
Free Cash Flow OCF − CapEx | $332.00K | $2.70M | $406.00K | $-2.68M |
Shares Outstanding | 16.46M | 16.44M | 16.44M | 16.45M |